Morgan Thomsen

The University of Copenhagen, in collaboration with Region Hovedstadens Psykiatri, is seeking a dedicated PhD student to join a pioneering research project in addiction science. Led by Senior Researcher and Associate Professor Morgan Thomsen, this project focuses on investigating the effectiveness of Cobenfy, a novel antipsychotic medication targeting muscarinic acetylcholine receptors, as a treatment for cocaine use disorder. The research will utilize rodent models to assess the drug's efficacy and explore its impact on brain function, contributing to the advancement of clinical trials in addiction treatment. This opportunity is ideal for candidates passionate about neuroscience, pharmacology, and addiction research. The project offers a unique chance to work at the intersection of neuropharmacology and clinical application, leveraging cutting-edge approaches to address substance use disorders. The University of Copenhagen provides a vibrant academic environment and access to state-of-the-art research facilities. Applicants should have a strong background in neuroscience, pharmacology, medical science, or related disciplines. Experience with rodent models, addiction research, or neuropharmacology is highly valued. The position is supervised by Morgan Thomsen, a leading expert in addiction research, ensuring mentorship and guidance throughout the PhD journey. For more information and to apply, interested candidates are encouraged to contact Morgan Thomsen or visit the LinkedIn post linked below. This is a unique opportunity to contribute to impactful research in the field of addiction and neuroscience at one of Europe's leading universities.